MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Hormone Use Linked To Increased Breast Cancer Risk

Back to breast cancer blog Blogs list Cancer blog  


Subscribe To Breast Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Hormone Use Linked To Increased Breast Cancer Risk

Hormone Use Linked To Increased Breast Cancer Risk
Hormone treatment appears to be associated with increased risk of breast cancer among black women, with a stronger link for leaner women, as per a research studyin the April 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Prior research has suggested that the long-term use of female hormone treatment is associated with an increased risk of developing breast cancer, as per background information in the article. However, most of the women in the largest studies have been white, and few studies have looked at the risks specifically in black women.

Lynn Rosenberg, Sc.D., of Slone Epidemiology Center, Boston University, and his colleagues examined the association in 23,191 women age 40 years or older who were part of the Black Women's Health Study, conducted by researchers at Boston University and Howard University, Washington, D.C. The participants filled out an initial questionnaire about medical history, menopausal status and hormone use when they enrolled in the study in 1995. Follow-up questionnaires that also included questions about the development of breast cancer were completed every two years through the year 2003. The women's body mass index (BMI) was calculated by dividing their weight in kilograms by the square of their height in meters.

During the course of the study, 615 cases of breast cancer were reported. Breast cancer was more likely to occur in women who had taken hormones, including estrogen or estrogen plus progestin, in the prior two years than in women who had never taken hormones. The longer a woman took hormones, the more likely she was to develop breast cancer, and the risk was slightly higher for women taking estrogen with progestin than for those taking progestin alone. The association between hormone use and breast cancer was strongest for women who were lean, defined as having a BMI of less than 25.

"Associations of exogenous [supplemental] female hormone use with increased risk of breast cancer are biologically plausible," the authors write. Estrogens produced by the body are associated with the development of breast cancer, and progestin is known to induce cell division in breast tissue, which could lead to a higher risk of cancer. The relationship may be stronger in lean women because fat tissue produces estrogen, so the extra hormones added by taking pills may not have as much of an effect on estrogen levels in heavier women.

"These results based on data from U.S. black women strengthen the evidence that use of estrogen alone and estrogen with progestin increases the risk of breast cancer and that the association is stronger among leaner women," the authors conclude.



Posted by: Janet    Source




Did you know?
Hormone treatment appears to be associated with increased risk of breast cancer among black women, with a stronger link for leaner women, as per a research studyin the April 10 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Prior research has suggested that the long-term use of female hormone treatment is associated with an increased risk of developing breast cancer, as per background information in the article. However, most of the women in the largest studies have been white, and few studies have looked at the risks specifically in black women.

Medicineworld.org: Hormone Use Linked To Increased Breast Cancer Risk

BREAST CANCER MAIN| Home| Breast cancer news| Common terms| Breast cancer treatment| Breast cancer treatment by stage| Mammogram and breast cancer screening| Surgical treatment of breast cancer| Chemotherapy of breast cancer| Chemo drugs used in breast cancer| Doxorubicin| Cyclophosphamide| Methotrexate| Hormonal therapy of breast cancer| Radiation therapy of breast cancer| Monoclonal therapy| High dose chemotherapy for breast cancer| Recurrent breast cancer| Bisphosphonates and breast cancer| Pregnancy and breast cancer| Risk factors for breast cancer| Risk details| My risk| Comprehensive breast cancer information| Breast cancer statistics| African Americans and breast cancer| Ashkenazi and breast cancer| Asians| Hispanic| Men| Native Americans| Older women and breast cancer| Younger women| Pregnant women and breast cancer| BRCA|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.